Kiran Mazumdar Shaw's most recent trade in Bicara Therapeutics Inc. was a trade of 23,746 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bicara Therapeutics Inc. | Kiran Mazumdar-Shaw | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2025 | 23,746 | 23,746 | - | - | Stock Option (Right to Buy) | |
| Bicara Therapeutics Inc. | Kiran Mazumdar-Shaw | Director, Ten Percent Owner | 12 Sep 2024 | 40,000,000 | 0 | - | - | Series Seed Redeemable Convertible Preferred Stock | ||
| Bicara Therapeutics Inc. | Kiran Mazumdar-Shaw | Director, Ten Percent Owner | 12 Sep 2024 | 9,990,144 | 0 | - | - | Series Seed Redeemable Convertible Preferred Stock | ||
| Bicara Therapeutics Inc. | Kiran Mazumdar-Shaw | Director, Ten Percent Owner | 12 Sep 2024 | 4,327,365 | 4,443,122 | - | 0 | Common Stock | ||
| Bicara Therapeutics Inc. | Kiran Mazumdar-Shaw | Director, Ten Percent Owner | 12 Sep 2024 | 4,000,000 | 0 | - | - | Series Seed Redeemable Convertible Preferred Stock | ||
| Bicara Therapeutics Inc. | Kiran Mazumdar-Shaw | Director, Ten Percent Owner | 12 Sep 2024 | 3,000,000 | 0 | - | - | Series Seed Redeemable Convertible Preferred Stock | ||
| Bicara Therapeutics Inc. | Kiran Mazumdar-Shaw | Director, Ten Percent Owner | 12 Sep 2024 | 1,080,775 | 1,080,775 | - | 0 | Common Stock | ||
| Bicara Therapeutics Inc. | Kiran Mazumdar-Shaw | Director, Ten Percent Owner | 12 Sep 2024 | 432,736 | 432,736 | - | 0 | Common Stock | ||
| Bicara Therapeutics Inc. | Kiran Mazumdar-Shaw | Director, Ten Percent Owner | 12 Sep 2024 | 324,552 | 324,552 | - | 0 | Common Stock | ||
| Bicara Therapeutics Inc. | Kiran Mazumdar-Shaw | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 23,746 | 23,746 | - | - | Stock Option (Right to Buy) | |
| PureTech Health Plc - ADR | Kiran Mazumdar Shaw | Non-Executive Director | 26 Jun 2024 | 17,122 | 49,819 (0%) | 0% | 0 | Ords 0.01p |